An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism

被引：126
|
作者：
Giannotti, F.
Cortesi, F.
Cerquiglini, A.
Bernabei, P.
机构：
[1] Univ Roma La Sapienza, Dept Dev Neurol & Psychiat, Ctr Pediat Sleep Disorders, I-00185 Rome, Italy
[2] Univ Roma La Sapienza, Dept Dev Neurol & Psychiat, PDD Clin, I-00185 Rome, Italy
来源：
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS | 2006年 / 36卷 / 06期
关键词：
sleep disorders; autism; melatonin treatment; long-term study;
D O I：
10.1007/s10803-006-0116-z
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
Long-term effectiveness of controlled-release melatonin in 25 children, aged 2.6-9.6 years with autism without other coexistent pathologies was evaluated openly. Sleep patterns were studied using Children's Sleep Habits Questionnaire (CSHQ) and sleep diaries at baseline, after 1-3-6 months melatonin treatment and 1 month after discontinuation. Sleep diary and CSHQ showed a more problematic sleep in autistic children compared with controls. During treatment sleep patterns of all children improved. After discontinuation 16 children returned to pre-treatment score, readministration of melatonin was again effective. Treatment gains were maintained at 12 and 24-month follow-ups. No adverse side effects were reported. In conclusion, controlled-release melatonin may provide an effective and well-tolerated treatment for autistic children with chronic sleep disorders.
引用
收藏
页码：741 / 752
页数：12
相关论文
共 50 条
  • [41] Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study
    Krakowiak, Paula
    Goodlin-Jones, Beth
    Hertz-Picciotto, Irva
    Croen, Lisa A.
    Hansen, Robin L.
    JOURNAL OF SLEEP RESEARCH, 2008, 17 (02) : 197 - 206
  • [42] Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism
    Carpenter, Kimberly
    Major, Samantha
    Tallman, Catherine
    Chen, Lyon
    Franz, Lauren
    Sun, Jessica
    Kurtzberg, Joanne
    Song, Allen
    Dawson, Geraldine
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S495 - S496
  • [43] ADHD treatment with once-daily OROS methylphenidate: Final results from a long-term open-label study
    Wilens, T
    McBurnett, K
    Stein, M
    Lerner, M
    Spencer, T
    Wolraich, M
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (10) : 1015 - 1023
  • [44] A new social communication intervention for children with autism: pilot randomised controlled treatment study suggesting effectiveness
    Aldred, C
    Green, J
    Adams, C
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2004, 45 (08) : 1420 - 1430
  • [45] The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study
    Masood Faghih Dinevari
    Farzaneh Jafarzadeh
    Amirreza Jabbaripour Sarmadian
    Samaneh Abbasian
    Zeinab Nikniaz
    Ali Riazi
    BMC Gastroenterology, 23
  • [46] The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study
    Dinevari, Masood Faghih
    Jafarzadeh, Farzaneh
    Sarmadian, Amirreza Jabbaripour
    Abbasian, Samaneh
    Nikniaz, Zeinab
    Riazi, Ali
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [47] Effecf of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: A randomized, double-blind, placebo-controlled study
    Garzón C.
    Guerrero J.M.
    Aramburu O.
    Guzmán T.
    Aging Clinical and Experimental Research, 2009, 21 (1) : 38 - 42
  • [48] A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis
    Finn, WF
    Joy, MS
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (05) : 657 - 664
  • [49] Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study
    Garzon, Cristina
    Guerrero, Juan M.
    Ararnburu, Oscar
    Guzman, Tomas
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 21 (01) : 38 - 42
  • [50] LONGER TERM TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY (BRIGHT [ZYN2-CL-030])
    Heussler, H.
    Duhig, M.
    Hurst, T.
    O'Neill, C.
    Gutterman, D.
    Palumbo, J. M.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2021, 65 (09) : 805 - 806
12345